Denali Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DNLI and other ETFs, options, and stocks.About DNLI
Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau.
DNLI Key Statistics
Stock Snapshot
The current Denali Therapeutics(DNLI) stock price is $19.39, with a market capitalization of 3.08B. The stock trades at a price-to-earnings (P/E) ratio of -6.73.
On 2026-05-15, Denali Therapeutics(DNLI) stock opened at $19.97, reached a high of —, and a low of —.
The Denali Therapeutics(DNLI)'s current trading volume is 1.34K, compared to an average daily volume of 1.86M.
During the past year, Denali Therapeutics(DNLI) stock moved between $12.58 at its lowest and $23.77 at its peak.
During the past year, Denali Therapeutics(DNLI) stock moved between $12.58 at its lowest and $23.77 at its peak.
Analyst ratings
95%
of 19 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.